Cancer patients navigating treatment and recovery need reliable tools to communicate their deepest concerns about disease progression and health outcomes. Effective measurement of these psychological burdens can transform how clinicians understand and respond to patient distress, potentially improving both treatment adherence and quality of life during critical phases of care.
Researchers validated a Spanish version of the Assessment of Survival Concerns scale using data from 1,052 metastatic cancer patients across multiple centers. The translated instrument demonstrated strong psychometric properties with omega reliability of 0.83 and excellent model fit statistics (RMSEA = 0.038, CFI = 0.998). The scale maintained measurement invariance across sex, age groups, and different tumor sites, indicating consistent performance regardless of patient demographics. Higher concern scores correlated positively with depression, anxiety, psychological distress, and physical symptom burden, confirming the instrument captures meaningful patient experiences.
This validation addresses a critical gap in Spanish-language cancer care assessment tools. Most psychometric instruments for cancer populations were developed in English-speaking contexts, potentially missing cultural nuances in how Spanish-speaking patients express health concerns. The demonstrated invariance across tumor types suggests the scale captures universal aspects of cancer-related worry rather than site-specific fears. However, the study focused exclusively on metastatic patients, limiting generalizability to earlier-stage cancers where concerns may differ substantially. The unidimensional structure also raises questions about whether the scale adequately captures the multifaceted nature of cancer-related concerns, from physical symptoms to social and financial impacts. This tool represents meaningful progress toward culturally appropriate cancer care assessment, though broader validation across cancer stages would strengthen its clinical utility.